eli lilly and company

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…

Eli Lilly and Company (NYSE:LLY) is among the Best Healthcare Stocks Stocks.On June 23, Reuters reported that Eli Lilly…

The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously…

In the national campaign Watch This, O’Neal gets real about living with moderate obstructive sleep apnea (OSA) and the…

Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…

In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all…

Eli Lilly and Company (NYSE:LLY) is one of the best low volatility stocks to invest in right now.…

Ajax’s lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with…

Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for…

Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1…

We just covered the Jim Cramer Stock Portfolio: Top 10 Stock Picks. Eli Lilly and Company (NYSE:LLY) ranks…

A safety alert has been issued after falsified Mounjaro pens were found. A safety alert has been issued…

Lilly’s triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes